Exact Mass: 518.3157788

Exact Mass Matches: 518.3157788

Found 500 metabolites which its exact mass value is equals to given mass value 518.3157788, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cucurbitacin F

2,3,16,20,25-Pentahydroxy-9-methyl-19-norlanosta-5,23-diene-11,22-dione (2beta,3alpha,9beta,10alpha,16alpha,23E)-

C30H46O7 (518.3243365999999)

(2R,6R)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptanoic acid

C30H46O7 (518.3243365999999)

Ganoderic acid C2 is a triterpenoid. CID 57396771 is a natural product found in Ganoderma lucidum with data available. Constituent of Ganoderma lucidum (reishi). Ganoderic acid C2 is found in mushrooms.

Cucurbitacin R

(2S,8S,9R,10R,13R,14S,16R,17R)-17-[(2R)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione

C30H46O7 (518.3243365999999)

23,24-dihydrocucurbitacin D is a 23,24-dihydrocucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at position 5. It is a 23,24-dihydrocucurbitacin, a secondary alpha-hydroxy ketone and a tertiary alpha-hydroxy ketone. 23,24-dihydrocucurbitacin D is a natural product found in Begonia heracleifolia, Conobea scoparioides, and other organisms with data available. A 23,24-dihydrocucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at position 5.

(2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid

C30H46O7 (518.3243365999999)

Odorosid A

ST 30:4;O7

3beta,16alpha,19,20beta,25-pentahydroxycucurbit-5,23-dien-11,22-dione

C30H46O7 (518.3243365999999)

Z-Glu-OtBu·DCHA

C29H46N2O6 (518.3355696)

N-cyclohexylcyclohexanamine,(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxo-5-phenylmethoxypentanoic acid

C29H46N2O6 (518.3355696)

BORTEZOMIB-PINANEDIOL

C29H39BN4O4 (518.3064204)

Bis(2,4-di-tert-butylphenyl)phenyl phosphonite

C34H47O2P (518.3313492)

zinc myristate

C28H54O4Zn (518.3313334)

Cbz-N-Me-Asp(OtBu)-OH

C29H46N2O6 (518.3355696)

Epelsiban

(2e,4e,6e)-9-{[(2s,3r)-4-{[(3e,5e)-1,7-dihydroxy-4-methyltetradeca-3,5-dien-1-ylidene]amino}-1,3-dihydroxy-2-methylbutylidene]amino}nona-2,4,6-trienoic acid

C29H46N2O6 (518.3355696)

(3r,3ar,5as,7as,8s,9r,10s,11s,11as,11bs,13as,13br)-9,10,11-trihydroxy-3-isopropyl-3a,5a,8,13a-tetramethyl-1h,2h,3h,4h,5h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-cyclopenta[a]chrysene-8,11a-dicarboxylic acid

methyl 2-methyl-4-oxo-6-{3,4,7-trihydroxy-6,6,9a,11a-tetramethyl-10-oxo-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}heptanoate

C30H46O7 (518.3243365999999)

beaumontoside

C30H46O7 (518.3243365999999)

{"Ingredient_id": "HBIN017670","Ingredient_name": "beaumontoside","Alias": "NA","Ingredient_formula": "C30H46O7","Ingredient_Smile": "CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)OC)O","Ingredient_weight": "518.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2187","TCMSP_id": "NA","TCM_ID_id": "6410;21739","PubChem_id": "45266905","DrugBank_id": "NA"}

(1r,2r,4r,6e,8s,9r)-9-hydroxy-6-[hydroxy(phenyl)methylidene]-1-methyl-4,8-bis(3-methylbut-2-en-1-yl)-2-(3-methylbut-3-en-1-yl)-10-oxatricyclo[6.2.1.0⁴,⁹]undecane-5,7-dione

C33H42O5 (518.3032082)

(1as,3s,4ar,5s,8r,8ar)-4a,5-dimethyl-2-oxo-3-(3-oxoprop-1-en-2-yl)-hexahydro-1ah-naphtho[4,4a-b]oxiren-8-yl (2r,3s,4e)-3-hydroxy-6-(hydroxymethyl)-2,4-dimethyldodec-4-enoate

C30H46O7 (518.3243365999999)

(1s,2s,4r,6s,8s,9r,10r,13s,14r,16s,17r,21s)-8,16,17,21-tetrahydroxy-6-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]-2,8,10,13,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-en-12-one

(1s,3as,3bs,7r,9s,9ar,9bs,11as)-1-[(2r,3r)-2,3-dihydroxy-4-[(3s,4r)-4-methyl-5-oxooxolan-3-yl]butan-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9-yl acetate

9-hydroxy-6-[hydroxy(phenyl)methylidene]-1-methyl-2,4,8-tris(3-methylbut-2-en-1-yl)-10-oxatricyclo[6.2.1.0⁴,⁹]undecane-5,7-dione

C33H42O5 (518.3032082)

(1r,2r,5r,8r,9r,10s,11r,13r,14r,15r,17s,18s)-8-(carboxymethyl)-11,17-dihydroxy-1,2,6,6,9-pentamethyl-15-(prop-1-en-2-yl)-7-oxapentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icosane-18-carboxylic acid

(1r,2r,3ar,3br,7r,8s,9ar,9br,11ar)-1-[(2s,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C30H46O7 (518.3243365999999)

(1r,3s,4s,4's,5s,8r,10s,13s,14s,16s,18s,19r,21r,22r)-3,21-dihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-8-yl acetate

(1r,3s,4s,4's,5s,8r,10s,13s,14s,16s,18s,19r,21r,22r)-3,21-dihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-8-yl acetate

C33H42O5 (518.3032082)

3-{2-hydroxy-2-[3-(2-{4-hydroxy-1,5,5-trimethyl-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl}ethyl)-2,2-dimethyl-6-methylidenecyclohexyl]ethylidene}oxolan-2-one

C30H46O7 (518.3243365999999)